2019
Change of Company Secretary – TAN KEAN WAI
NOVA MSC BERHAD 08 Nov 2019 Date Of Change 07 Nov 2019 Type Of Change Appointment Designation Company Secretary License No MAICSA 7056310 Name TAN KEAN WAI Working experience and occupation during past 5 years
Change of Company Secretary – NIP CHEE SIEN
NOVA MSC BERHAD 08 Nov 2019 Date Of Change 07 Nov 2019 Type Of Change Resignation Designation Company Secretary License No MAICSA 7066996 Name NIP CHEE SIEN Working experience and occupation during past 5 years Mr Nip is an Associate of The Malaysian Institute of Chartered Secretaries and Administrators (MAICSA) and has 11 years of working experiences in corporate secretarial…
Change of Company Secretary – TAN KOK AUN
NOVA MSC BERHAD 08 Nov 2019 Date Of Change 07 Nov 2019 Type Of Change Resignation Designation Joint Secretary License No MACS 01564 Name TAN KOK AUN Working experience and occupation during past 5 years
Change of Address
NOVA MSC BERHAD 08 Nov 2019 Change description REGISTERED Old address No. 1 & 1A, 2nd Floor Jalan Ipoh Kecil 50350 Wilayah Persekutuan Malaysia New address No. 5-1, Jalan Radin Bagus 9, Bandar Baru Sri Petaling 57000 Kuala Lumpur Wilayah Persekutuan Malaysia Telephone No 03 -90541498 Facsimile No 03 -90541498 E-mail address kentz.tan@innext.com.my Effective date 07 Nov 2019 Change description…
REGULATORY BODY APPROVES MARKETING OF SELENA+ THAT CAN DETECT 3 EYE DISEASES
Oct 2019 – It is with great pleasure to announce EyRIS’s first medical device after Heath Science Authority of Singapore (HSA) gave us the official approval. Our medical device, SELENA+, is an effective assistive tool in the diagnosis of 3 eye diseases, diabetic retinopathy (DR), Glaucoma and Age-Related Macular Degeneration (AMD). This approval closely follows the ISO13485:2016 certification we received…
Change of Address
NOVA MSC BERHAD 16 Oct 2019 Change description REGISTRAR Old address Level 6, Symphony House Pusat Dagangan Dana 1 Jalan PJU 1A/46 47301 Petaling Jaya Selangor Malaysia New address 11th Floor, Menara Symphony No. 5, Jalan Prof. Khoo Kay Kim Seksyen 13 46200 Petaling Jaya Selangor Malaysia Name of Registrar BOARDROOM SHARE REGISTRARS SDN BHD Telephone No 03 -78904700 Facsimile…
Changes in Director’s Interest (Section 219 of CA 2016) – MR DAVID CHOO BOON LEONG
NOVA MSC BERHAD 07 Oct 2019 Particulars of Director Name MR DAVID CHOO BOON LEONG Descriptions(Class) Ordinary shares Details of changes No Date of change No of securities Type of transaction Nature of Interest 1 04/10/2019 50,000 Acquired Direct Interest Name of registered holder David Choo Boon Leong Description of “Others” Type of Transaction Consideration (if any) Circumstances by…
EYRIS QUALITY MANAGEMENT SYSTEM RECEIVES ISO 13485 ACCREDITATION
Sep 2019 – We are proud to announce that EyRIS’s Quality Management System (QMS) was officially accredited with ISO 13485:2016 on the 21 Aug 2019 after completing an audit conducted by SGS S.A. The accreditation reaffirms the international standards adopted by EyRIS in the design and manufacture of medical devices. The management would like to recognise and thank the team…
VESALIUS TO BE IMPLEMENTED IN THAILAND
Sep 2019 – The School of Medicine, University of Phayao was established in 2008 to train medical students, traditional medicine and allied health practitioners in Phayao Province, northern Thailand. Subsequently, a hospital was planned and constructed for the continued practical education. The newly constructed University of Phayao Medical Center and Hospital (UPMED) is located in the pristine hillside in the…
EYRIS FOUNDER WINS NATIONAL CLINICAL EXCELLENCE TEAM AWARD
Sep 2019 – EyRIS extends our heartiest congratulations to our founder Haslina Hamzah and collaborator Dr. Gavin Tan on winning the National Clinical Excellence Team Award. Their innovative approach in transforming the way digital fundus images are screened for diabetic retinopathy, a leading cause of vision impairment. The devised scheme, Singapore integrated Diabetic Retinopathy Program (SiDRP), has shortened the time…
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PRIVATE PLACEMENT OF UP TO 30% OF THE ISSUED AND PAID-UP SHARE CAPITAL OF NOVAMSC (“PRIVATE PLACEMENT”)
NOVA MSC BERHAD 20 Sep 2019 Unless stated otherwise, the terms used herein shall carry the same meaning as those defined in the earlier announcements in relation to the Private Placement. We refer to our earlier announcements dated 27 February 2019, 7 March 2019, 20 March 2019 and 30 August 2019 in relation to the Private Placement. On behalf of…
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PRIVATE PLACEMENT OF UP TO 30% OF THE ISSUED AND PAID-UP SHARE CAPITAL OF NOVAMSC (“PRIVATE PLACEMENT”)
NOVA MSC BERHAD 30 Aug 2019 Unless stated otherwise, the terms used herein shall carry the same meaning as those defined in the earlier announcements in relation to the Private Placement. We refer to our earlier announcements dated 27 February 2019, 7 March 2019 and 20 March 2019 in relation to the Private Placement. On behalf of NOVAMSC, UOBKH had…